High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration
Objective: To analyze the differential expression and prognostic value of Mitochondrial ribosomal protein L52 (MRPL52) in hepatocellular carcinoma using bioinformatics, and to explore the prognostic value and role of the MRPL52 in the immune regulation of hepatocellular carcinoma. Methods: Hepatocel...
Saved in:
| Main Authors: | Nan HUANG, Xiang LIU, Qichang XING, Jia CHEN, Xiaolan GUO, Wei LI, Zheng LIU |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2021-12-01
|
| Series: | Journal of Holistic Integrative Pharmacy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2707368823000754 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker
by: Wenya Xing, et al.
Published: (2025-01-01) -
Suppression of MRPL23 induces cellular senescence in hepatocellular carcinoma by targeting HMGB1
by: Ya-Bin Huang, et al.
Published: (2025-06-01) -
Targeting liver cancer stem cells: the prognostic significance of MRPL17 in immunotherapy response
by: Jingjing Shao, et al.
Published: (2024-12-01) -
Identifying the mitochondrial ribosomal protein MRPL13 as an oncogenic RBP that promotes proliferation, migration, and anti-apoptotic effects in esophageal cancer cells
by: Yaxi Song, et al.
Published: (2025-05-01) -
MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway
by: Rui Guan, et al.
Published: (2025-07-01)